Safety and efficacy of the combined use of UNISTRAIN PRRS® and AUSKIPRA® GN administered by the intradermal and intramuscular routes under field conditions

Startseite Know-how Safety and efficacy of the combined use of UNISTRAIN PRRS® and AUSKIPRA® GN administered by the intradermal and intramuscular routes under field conditions

Safety and efficacy of the combined use of UNISTRAIN PRRS® and AUSKIPRA® GN administered by the intradermal and intramuscular routes under field conditions

The aim of this study was to demonstrate that the association of UNISTRAIN® PRRS and AUSKIPRA® GN applied by intradermal (ID) or intramuscular route (IM) were as safe and efficacious as when applied separately. 

Über diesen Artikel

Veröffentlicht in

IPVS Congress China, 2018

Datum

16.07.2018

Verfasser

Simon-Grifé, M., Fenech, M.; Colomé, M.; Acal, L.; Sitja, M.; March, R.

Zusammenfassung

lt was demonstrated that the association of UNISTRAIN® PRRS and AUSKIPRA® GN administered by the intradermal and intramuscular routes is as safe and efficacious as the administration of both products separately.

Teilen